KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Capital Leases: 2015-2018

Historic Capital Leases for Medpace Holdings (MEDP) over the last 2 years, with Dec 2018 value amounting to $24.5 million.

  • Medpace Holdings' Capital Leases fell 7.96% to $24.5 million in Q4 2018 from the same period last year, while for Dec 2018 it was $24.5 million, marking a year-over-year decrease of 7.96%. This contributed to the annual value of $24.5 million for FY2018, which is 7.96% down from last year.
  • According to the latest figures from Q4 2018, Medpace Holdings' Capital Leases is $24.5 million, which was down 2.20% from $25.0 million recorded in Q3 2018.
  • Medpace Holdings' 5-year Capital Leases high stood at $30.3 million for Q4 2015, and its period low was $24.5 million during Q4 2018.
  • For the 3-year period, Medpace Holdings' Capital Leases averaged around $26.8 million, with its median value being $26.9 million (2017).
  • Data for Medpace Holdings' Capital Leases shows a maximum YoY fell of 7.96% (in 2018) over the last 5 years.
  • Medpace Holdings' Capital Leases (Quarterly) stood at $30.3 million in 2015, then fell by 5.77% to $28.5 million in 2016, then decreased by 6.75% to $26.6 million in 2017, then declined by 7.96% to $24.5 million in 2018.
  • Its last three reported values are $24.5 million in Q4 2018, $25.0 million for Q3 2018, and $25.6 million during Q2 2018.